Stock Events

Stock Events

Transmedics Group 

$134.5
1973
+$0.53+0.39% Today

Statistics

Day High
139.46
Day Low
132.01
52W High
150.42
52W Low
64.35
Volume
856,121
Avg. Volume
797,488
Mkt Cap
4.6B
P/E Ratio
51.79
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
0.12
0.39
0.65
0.92
Expected EPS
0.389421
Actual EPS
N/A

Financials

8.03%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
883.08MRevenue
70.93MNet Income

Analyst Ratings

$143.43Average Price Target
The highest estimate is 166.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
71%
Hold
29%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TMDX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers a range of medical devices and technologies that can compete with TransMedics' organ transplantation solutions.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories provides a broad portfolio of medical devices, including those for cardiovascular and neuromodulation, which can be seen as indirect competitors to TransMedics' offerings.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation competes in the medical devices sector, offering products that could be used in cardiovascular procedures, potentially competing with TransMedics' organ preservation technologies.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products, which could be used in procedures that compete with TransMedics' transplantation solutions.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation focuses on patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring, which could indirectly compete with TransMedics' technologies.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. offers musculoskeletal healthcare solutions, which could be seen as competing in the broader medical devices market against TransMedics' organ preservation and transplantation technologies.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. develops, manufactures, and markets robotic products for minimally invasive surgery, which could compete with TransMedics in the surgical and transplantation market.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a portfolio of healthcare products, including renal and hospital products, which could compete with TransMedics' organ preservation solutions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the healthcare field with a broad range of products. Its medical devices segment could indirectly compete with TransMedics in various areas, including surgical technologies.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on diagnostics, medical imaging systems, and surgical products for women's health, which could compete in the broader healthcare and medical devices market against TransMedics.

About

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Show more...
CEO
Dr. Waleed H. Hassanein M.D.
Employees
728
Country
US
ISIN
US89377M1099

Listings

MX
MX
TMDX.MX
MI
IT
1TMDX.MI
F
DE
8T8.F
XNAS
US
TMDX

0 Comments

Share your thoughts

FAQ

What is Transmedics Group stock price today?▼
The current price of TMDX is $134.5 USD — it has increased by +0.39% in the past 24 hours. Watch Transmedics Group stock price performance more closely on the chart.
What is Transmedics Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Transmedics Group stocks are traded under the ticker TMDX.
Is Transmedics Group stock price growing?▼
TMDX stock has fallen by -4.18% compared to the previous week, the month change is a +8.82% rise, over the last year Transmedics Group has showed a +97.65% increase.
What is Transmedics Group market cap?▼
Today Transmedics Group has the market capitalization of 4.6B
When is the next Transmedics Group earnings date?▼
Transmedics Group is going to release the next earnings report on March 04, 2026.
What were Transmedics Group earnings last quarter?▼
TMDX earnings for the last quarter are 0.66 USD per share, whereas the estimation was 0.36 USD resulting in a +83.06% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Transmedics Group revenue for the last year?▼
Transmedics Group revenue for the last year amounts to 883.08M USD.
What is Transmedics Group net income for the last year?▼
TMDX net income for the last year is 70.93M USD.
How many employees does Transmedics Group have?▼
As of February 02, 2026, the company has 728 employees.
In which sector is Transmedics Group located?▼
Transmedics Group operates in the Health Care sector.
When did Transmedics Group complete a stock split?▼
Transmedics Group has not had any recent stock splits.
Where is Transmedics Group headquartered?▼
Transmedics Group is headquartered in Andover, US.